Asthma: Specific clinical and functional characteristics in childhood. Results of a national program in Romanian asthmatic children

European Annals of Allergy and Clinical Immunology

Volumn 42, Issue 5, 2010, Pages 186-193

  Badiu Decleyre, I ^a,b   Thumerelle, C ^a   Gotia, S ^b   Duhamel, A ^a   Santos, C ^a   Deschildre, A ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Department of Pediatrics   (Romania)

Author keywords

Asthma; Child; Control; Lung function; Prospective study; Romania; Severity

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; SALBUTAMOL;

ADOLESCENT; ARTICLE; CHILD; CLINICAL FEATURE; DISEASE CONTROL; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH PROGRAM; HOSPITALIZATION; HUMAN; LUNG FUNCTION; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MILD INTERMITTENT ASTHMA; MILD PERSISTENT ASTHMA; MODERATE PERSISTENT ASTHMA; PROSPECTIVE STUDY; ROMANIA; SCHOOL CHILD; SEVERE PERSISTENT ASTHMA;

ADOLESCENT; AGE FACTORS; ASTHMA; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; PRACTICE GUIDELINES AS TOPIC; PROGNOSIS; PROGRAM EVALUATION; RESPIRATORY FUNCTION TESTS; ROMANIA;

EID: 77958608382     PISSN: 03979148     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Asher MI, Montefort S, Björkstén B, et al. ISAAC Phase Three Study Group.Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet 2006; 368: 733-43. (Pubitemid 44279052)
2. Weinmayr G, Weiland SK, Björkstén B, et al. ISAAC Phase Two Study Group. Atopic sensitization and the international variation of asthma symptom prevalence in children. Am J Respir Crit Care Med 2007; 176:565-74.
3. Global Initiative for Asthma (GINA), Global strategy for asthma management and prevention. NHLBI/WHO workshop report. National Institutes of Health, National Heart, Lung and Blood Institute (1995) National Institutes of Health publication no. 95-3659.
4. American Thoracic Society Statement. Standardization of spirometry - 1987 update. Am Rev Respir Dis 1987; 136: 1285-98.
5. Polgar G, Promadhat V. Pulmonary function testing in children: techniques and standards. 1rst ed. Philadelphia, Saunders, 1971.
6. Hamouda S, Karila C, Connault T, Scheinmann P, de Blic J. Allergic rhinitis in children with asthma: a questionnaire-based study. Clin Exp Allergy 2008; 38: 761-6. (Pubitemid 351550668)
7. Cabral AL, Conceição GM, Fonseca-Guedes CH, Martins MA. Exercise-induced bronchospasm in children: effects of asthma severity. Am J Respir Crit Care Med 1999; 159: 1819-23.
8. Rabe KF, Adachi M, Lai CK, et al.Worldwide severity and control of asthma in children and adults: the global asthma insights and reality surveys. J Allergy Clin Immunol 2004; 114: 40-7. (Pubitemid 39022491)
9. Miller MK, Johnson C, Miller DP, et al. Severity assessment in asthma: an evolving concept. J Allergy Clin Immunol 2005; 116: 990-5. (Pubitemid 41571777)
10. Dusser D, Montani D, Chanez P, et al. Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations. Allergy 2007; 62: 591-604. (Pubitemid 46763450)
11. Bacharier LB, Dawson C, Bloomberg GR, Bender B, Wilson L, Strunk RC. Hospitalisation for asthma: atopy, pulmonary function and psychological correlates among participants in the childhood asthma management program (CAMP). Pediatrics 2003; 112: 85-92.
12. Wildhaber JH, Sznitman J, Harpes P, et al. Correlation of spirometry and symptom scores in childhood asthma and the usefulness of curvature assessment in expiratory flow-volume curves. Respir Care 2007; 52:1744-52.
13. Paull K, Covar R, Jain N, Gelfand EW, Spahn JD. Do NHLBI lung criteria apply to children? A cross-sectional evaluation of childhood asthma at National Jewish Medical and Research Center, 1999-2002. Pediatr Pulmonol 2005; 39: 311-17.
14. Baatenburg de Jong A, Brouwer AF, Roorda RJ, Brand PL. Normal lung function in children with mild to moderate persistent asthma well controlled by inhaled corticosteroids. J Allergy Clin Immunol 2006; 118: 280-82.
15. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63 (Suppl 86): 8-160
16. Calhoun WJ, Sutton LB, Emmett A, Dorinsky PM. Asthma variability in patients previously treated with beta2-agonists alone. J Allergy Clin Immunol 2003; 112: 1088-94. (Pubitemid 37549999)
17. Chipps BE, Spahn JD, Sorkness CA, et al. Variability in asthma severity in pediatric subjects with asthma previously receiving short-acting beta2-agonists. J Pediatr 2006; 148: 517-21.
18. Stempel DA, McLaughlin TP, Stanford RH, Fuhlbrigge AL. Patterns of asthma control: a 3-year analysis of patient claims. J Allergy Clin Immunol 2005; 115: 935-9.
19. Petsky HL, Cates CJ, Li A, Kynaston JA, Turner C, Chang AB. Tailored interventions based on exhaled nitric oxide versus clinical symptoms for asthma in children and adults. Cochrane Database Syst Rev 2009 (4): CD006340.
20. Lanier B, Bridges T, Kulus M, Taylor AF, Berhane I, Vidaurre CF. Omalizumab for the treatment of exacerbations in children with inadequately controlled allergic (IgE-mediated) asthma. J Allergy Clin Immunol 2009; 124: 1210-6.
21. Covar RA, Spahn JD, Murphy JR, Szefler SJ; Childhood Asthma Management Program Research Group. Progression of asthma measured by lung function in the childhood asthma management program. Am J Respir Crit Care Med 2004; 170: 234-41.
22. De Marco R, Locatelli F, Cerveri I, et al. Incidence and remission of asthma: a retrospective study on the natural history of asthma in Italy. J Allergy Clin Immunol 2002; 110: 228-35.
23. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-78.